Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine for Panic Disorder
NCT01680107Phase 3Terminated
- Sponsor
- University of Oxford
- Start
- Oct 2012
- Primary completion
- Oct 2017
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of d-cycloserine in panic disorder, sponsored by University of Oxford. Started Oct 2012; status: terminated.
02
Drugs
d-cycloserine
03
Conditions
panic disorder
Beyond the preview
Go deeper on NCT01680107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01680107.